State Street’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.27B Buy
67,986,847
+2,140,788
+3% +$171M 0.15% 121
2025
Q4
$6.28B Buy
65,846,059
+920,495
+1% +$90.2M 0.21% 86
2025
Q3
$6.34B Sell
64,925,564
-266,300
-0.4% -$27.6M 0.22% 86
2025
Q2
$7B Buy
65,191,864
+713,379
+1% +$72.2M 0.26% 66
2025
Q1
$6.5B Buy
64,478,485
+514,793
+0.8% +$51.8M 0.27% 68
2024
Q4
$5.71B Buy
63,963,692
+1,117,364
+2% +$98.4M 0.23% 78
2024
Q3
$5.27B Buy
62,846,328
+1,389,172
+2% +$110M 0.21% 82
2024
Q2
$4.73B Sell
61,457,156
-1,271,103
-2% -$93M 0.21% 88
2024
Q1
$4.3B Buy
62,728,259
+393,653
+0.6% +$25.3M 0.19% 102
2023
Q4
$3.6B Buy
62,334,606
+388,750
+0.6% +$20.8M 0.18% 115
2023
Q3
$3.27B Sell
61,945,856
-1,246,041
-2% -$65.3M 0.18% 111
2023
Q2
$3.42B Buy
63,191,897
+1,157,186
+2% +$60.4M 0.18% 106
2023
Q1
$3.1B Sell
62,034,711
-1,523,465
-2% -$71.8M 0.18% 116
2022
Q4
$2.94B Sell
63,558,176
-365,616
-0.6% -$15.8M 0.17% 120
2022
Q3
$2.48B Buy
63,923,792
+252,827
+0.4% +$10.1M 0.16% 132
2022
Q2
$2.37B Buy
63,670,965
+447,651
+0.7% +$18.2M 0.14% 148
2022
Q1
$2.8B Sell
63,223,314
-1,073,440
-2% -$46.5M 0.14% 140
2021
Q4
$2.73B Buy
64,296,754
+1,746,588
+3% +$73.4M 0.13% 141
2021
Q3
$2.71B Buy
62,550,166
+677,714
+1% +$30M 0.14% 131
2021
Q2
$2.65B Sell
61,872,452
-1,764,199
-3% -$74.2M 0.14% 131
2021
Q1
$2.46B Sell
63,636,651
-1,436,037
-2% -$54.4M 0.14% 134
2020
Q4
$2.34B Buy
65,072,688
+1,201,986
+2% +$43.3M 0.14% 135
2020
Q3
$2.44B Sell
63,870,702
-794,785
-1% -$30.6M 0.17% 117
2020
Q2
$2.27B Buy
64,665,487
+2,442,104
+4% +$87.9M 0.17% 120
2020
Q1
$2.03B Buy
62,223,383
+1,967,227
+3% +$76.9M 0.18% 114
2019
Q4
$2.72B Buy
60,256,156
+1,080,641
+2% +$45.2M 0.19% 108
2019
Q3
$2.41B Sell
59,175,515
-601,377
-1% -$25.5M 0.18% 113
2019
Q2
$2.57B Buy
59,776,892
+540,657
+0.9% +$20.8M 0.19% 105
2019
Q1
$2.27B Buy
59,236,235
+2,556,913
+5% +$97.7M 0.18% 113
2018
Q4
$2B Buy
56,679,322
+2,869
+0% +$104K 0.18% 111
2018
Q3
$2.18B Buy
56,676,453
+2,562,620
+5% +$89.5M 0.17% 120
2018
Q2
$1.77B Buy
54,113,833
+2,505,004
+5% +$75.6M 0.15% 140
2018
Q1
$1.41B Sell
51,608,829
-5,436,233
-10% -$148M 0.12% 176
2017
Q4
$1.41B Sell
57,045,062
-477,720
-0.8% -$13.2M 0.11% 182
2017
Q3
$1.68B Buy
57,522,782
+360,757
+0.6% +$9.96M 0.14% 146
2017
Q2
$1.58B Sell
57,162,025
-446,091
-0.8% -$11.8M 0.14% 150
2017
Q1
$1.43B Sell
57,608,116
-3,872,919
-6% -$94.2M 0.13% 167
2016
Q4
$1.33B Buy
61,481,035
+1,907,944
+3% +$41.6M 0.13% 177
2016
Q3
$1.42B Buy
59,573,091
+7,898,144
+15% +$188M 0.14% 155
2016
Q2
$1.21B Buy
51,674,947
+248,594
+0.5% +$5.38M 0.13% 166
2016
Q1
$967M Sell
51,426,353
-965,204
-2% -$17M 0.1% 211
2015
Q4
$966M Buy
52,391,557
+379,595
+0.7% +$6.8M 0.11% 205
2015
Q3
$854M Sell
52,011,962
-299,345
-0.6% -$5.12M 0.1% 216
2015
Q2
$926M Sell
52,311,307
-2,305,361
-4% -$41.2M 0.1% 219
2015
Q1
$969M Sell
54,616,668
-1,611,785
-3% -$25.5M 0.1% 216
2014
Q4
$745M Buy
56,228,453
+743,299
+1% +$9.5M 0.07% 275
2014
Q3
$655M Buy
55,485,154
+1,991,859
+4% +$25.1M 0.07% 283
2014
Q2
$683M Buy
53,493,295
+247,133
+0.5% +$3.21M 0.07% 275
2014
Q1
$720M Sell
53,246,162
-2,842,506
-5% -$37.3M 0.08% 244
2013
Q4
$674M Buy
56,088,668
+1,008,380
+2% +$11.9M 0.08% 274
2013
Q3
$647M Sell
55,080,288
-684,164
-1% -$7.4M 0.08% 255
2013
Q2
$517M Buy
+55,764,452
New +$473M 0.07% 300

Other funds holding BSX